نتایج جستجو برای: β thalassemia

تعداد نتایج: 195979  

Journal: :international journal of reproductive biomedicine 0
sedigheh amooee alamtaj samsami jamileh jahanbakhsh mehran karimi

background:   objective: to determine pregnancy outcome of women with β-thalassemia minor.   materials and methods: in this retrospective, case-control study in two universities affiliated hospitals in shiraz, all pregnancies occurred between 2006 and 2008 were included. patients were divided in two groups regarding the presence of β-thalassemia minor. patients in case and control groups were m...

2013
Min Lin Ying-Fang Wen Jiao-Ren Wu Qian Wang Lei Zheng Gui-Rong Liu Yue Huang Hui Yang Fen Lin Xiao-Fen Zhan Chun-Ping Lin Hui-Tian Yang Qiu-Qing Weng Fen-Ting Huang Yuan Wang Mei-Qiong Yao Hui-Zhou Chen Di-Hong Wu Jing-Bo Zeng Ri-Xin Zeng Hua Yang Gui-Cai Li Min Lu Juan-Juan Zhu Long-Xu Xie Jun-Li Wang Li-Ye Yang

BACKGROUND Hemoglobinopathies are the most common inherited diseases in southern China. However, there have been only a few epidemiological studies of hemoglobinopathies in Guangdong province. MATERIALS AND METHODS Peripheral blood samples were collected from 15299 "healthy" unrelated subjects of dominantly ethnic Hakka in the Meizhou region, on which hemoglobin electrophoresis and routine bl...

Journal: :International Journal of Health Sciences (IJHS) 2022

Sclrostin is a biomarker interrupted in bone resorption process by binding to LRP5 and/or LRP6 family, and prevent Wingless-type signaling (Wnt) which important both development the maintain of mass. Sixty (60) patients with thalassemia major were enrolled from period 2/5/2021 1/9/2021 summer assessment role sclrostin predisposing for osteoporosis β-thalassemia (β-TM). Patients ages (2-40 year)...

Journal: :European journal of haematology 2015
Jacqueline S Guimarães Juçara G Cominal Ana Cristina Silva-Pinto Gordana Olbina Yelena Z Ginzburg Vijay Nandi Mark Westerman Stefano Rivella Ana Maria de Souza

The thalassemia syndromes (α- and β-thalassemia) are the most common and frequent disorders associated with ineffective erythropoiesis. Imbalance of α- or β-globin chain production results in impaired red blood cell synthesis, anemia, and more erythroid progenitors in the blood stream. While patients affected by these disorders show definitive altered parameters related to erythropoiesis, the r...

Journal: :international journal of hematology-oncology and stem cell research 0
majid farshdousti hagh division of laboratory hematology and blood banking, faculty of medicine, tabriz university of medical sciences, tabrez, iran ali dehghani fard department of hematology and blood banking, faculty of medical sciences, tarbiat modares university,tehran, iran najmaldin saki research center of thalassemia and hemoglobinopathies, ahvaz jundishapur university of medical sciences, ahvaz, iran mohammad shahjahani department of hematology and blood banking, faculty of medical sciences, tarbiat modares university,tehran, iran saied kaviani department of hematology and blood banking, faculty of medical sciences, tarbiat modares university,tehran, iran

hemoglobin f (hbf, α 2 γ 2 ) is a major contributor to the clinical heterogeneity and ameliorating agent observed in patients with the β-globin disorders including β-thalassemia and sickle cell disease (scd). during fetal life, hbf is the major hemoglobin but is largely substituted by adult hemoglobin (hba, α 2 β 2 ) following a globin expression switch after birth. increased γ-globin expressio...

Journal: :iranian biomedical journal 0
محمد حمید mohammad hamid فروزنده محجوبی frouzandeh mahjoubi محمدتقی اکبری mohammad taghi akbari حسین خان احمد hossein khanahmad فاطمه جمشیدی fatemeh jamshidi سیروس زینلی sirous zeinali مرتضی کریمی پور

background: in the previous study, we have shown that the presence of a allele at position -588 in aγ-globin gene was highly frequent and closely associated with fetal hemoglobin elevation among β-thalassemia intermedia patients. therefore, we decided to investigate whether this allele (a allele at -588) could result in an increase in aγ-globin gene expression to ameliorate the severity of the ...

Journal: :international journal of hematology-oncology and stem cell research 0
mohammad ali jalali far health research institute, research center of thalassemia & hemoglobinopathy, ahvaz jundishapur university of medical sciences, ahvaz, iran ali dehghani fard sarem cell research center-scrc, sarem women’s hospital, tehran, iran saiedeh hajizamani diagnosticlaboratory sciences and technology research center, school of paramedical sciences, shiraz university of medical sciences, shiraz, iran majid mossahebi-mohammadi department of hematology, faculty of medical sciences, tarbiat modares university, tehran, iran hamid yaghooti department of medical laboratory sciences, school of paramedicine, ahvaz jundishapur university of medical sciences, ahvaz, iran najmaldin saki health research institute, research center of thalassemia & hemoglobinopathy, ahvaz jundishapur university of medical sciences, ahvaz, iran

background: efficient induction of fetal hemoglobin (hbf) is considered as an effective therapeutic approach in beta thalassemia. hbf inducer agents can induce the expression of γ-globin gene and produce high levels of hbf via different epigenetic and molecular mechanisms. thalidomide and sodium butyrate are known as hbf inducer drugs. material and methods : cd133 + stem cells were isolated fro...

2011
Ekati Drakopoulou Eleni Papanikolaou Nicholas P. Anagnou

β-thalassemia is characterized by reduced or absence of β-globin production, resulting in anemia. Current therapies include blood transfusion combined with iron chelation. BM transplantation, although curative, is restricted by the matched donor limitation. Gene therapy, on the other hand, is promising, and its success lies primarily on designing efficient globin vectors that can effectively an...

2018
Idit Lachover Roth Boaz Lachover Guy Koren Carina Levin Luci Zalman Ariel Koren

Background β-thalassemia major is a severe disease with high morbidity. The world prevalence of carriers is around 1.5-7%. The present study aimed to find a reliable formula for detecting β-thalassemia carriers using an extensive database of more than 22,000 samples obtained from a homogeneous population of childbearing age women with 3161 (13.6%) of β-thalassemia carriers and to check previous...

2012
B M Jha

Background: Since many surveys for the prevalence of β thalassemia have been made in area with high prevalence of malaria, it is important to find out whether malaria can modify Hb A2 levels. In present study, analysis of Hb A2 level of patients with malaria and thalassemia has been done and has been compared with control group to conclude that whether Hb A2 level was affected or not. Methodolo...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید